🧬 Is your metabolism quietly signaling the earliest signs of future disease?

🔗 Metabolic phenotypes: Molecular bridges between health homeostasis and disease imbalance. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.10.057

📚 CSBJ: https://www.csbj.org/

#MetabolicPhenotyping #Metabolomics #PrecisionMedicine #MultiOmics #BiomarkerDiscovery #TranslationalMedicine #DiseasePrevention #AIinHealthcare

Scientific Director
CureGRIN Foundation

CureGRIN is looking for a brilliant, driven, junior PhD who will work remotely with researchers, clinicians, industry and patient families.

See the full job description on jobRxiv: https://jobrxiv.org/job/curegrin-foundation-27778-scientific-director/

#clinicaltrial #communityengagement #preclinical #rarediseases #Translationalmedicine #ScienceJobs #hiring #research
https://jobrxiv.org/job/curegrin-foundation-27778-scientific-director/?fsp_sid=3847

Scientific Director
CureGRIN Foundation

CureGRIN is looking for a brilliant, driven, junior PhD who will work remotely with researchers, clinicians, industry and patient families.

See the full job description on jobRxiv: https://jobrxiv.org/job/curegrin-foundation-27778-scientific-director/

#clinicaltrial #communityengagement #preclinical #rarediseases #Translationalmedicine #ScienceJobs #hiring #research
https://jobrxiv.org/job/curegrin-foundation-27778-scientific-director/?fsp_sid=3742

A groundbreaking discovery is giving new hope to patients with Alzheimer’s and Parkinson’s. Scientists have developed tiny antibodies capable of rapidly targeting harmful protein clumps that drive these neurodegenerative diseases. These protein aggregates, such as beta-amyloid in Alzheimer’s and alpha-synuclein in Parkinson’s, disrupt brain cells and lead to memory loss, tremors, and cognitive decline.

Unlike traditional therapies, these miniature antibodies can penetrate brain tissue more efficiently and clear the toxic proteins faster. Early lab studies show they can neutralise and remove clumps before they cause severe damage, potentially slowing or even preventing disease progression.

This innovation could pave the way for faster, more effective treatments that go straight to the root cause of these devastating conditions. By using these tiny antibodies, researchers hope to develop therapies that are both powerful and precise, offering patients a better quality of life and renewed hope for the future.

While human trials are still needed, this breakthrough marks a significant step toward fighting diseases that have long eluded effective treatment. The combination of speed, precision, and targeted action makes these tiny antibodies one of the most promising advancements in neurodegenerative research.

Neurodegenerative diseases
#Alzheimers #Parkinsons #Neurodegeneration #DementiaResearch #BrainHealth

Therapeutics & biotech
#AntibodyTherapy #Biotech #MedicalBreakthrough #NeuroTherapeutics #PrecisionMedicine

Research & innovation
#Neuroscience #NeuroResearch #CuttingEdgeScience #FutureOfMedicine #TranslationalMedicine

General science & hope
#HealthInnovation #LifeSciences #HopeForCures #MedicalInnovation #ScienceNews

Nanoparticles That Hunt Plaque and Heal Arteries? It’s Happening.

Imagine a tiny tool—thousands of times smaller than a human hair—that can find and shrink dangerous plaque in your arteries without traditional drugs. That’s exactly what researchers in Australia and Canada have developed with a new class of “theranostic” nanoparticles.

Called Por-NPs, these microscopic particles target the immune cells in artery walls that absorb cholesterol. When overwhelmed, these cells become foam cells and contribute to artery-clogging plaques—a major cause of heart attacks and strokes. The nanoparticles not only detect these trouble spots using fluorescence or PET scans, but they also reduce inflammation and help these immune cells unload cholesterol, disrupting the cycle that drives heart disease.

In tests on mice prone to atherosclerosis and fed a high-fat diet, the results were striking: plaque size shrank by up to 52%, and inflammation dropped dramatically. Most of the nanoparticles then traveled safely to the liver—where they deposited the excess cholesterol for natural processing.

This dual-action approach is still experimental but holds promise as a powerful new way to see and treat cardiovascular disease at the same time—possibly even before symptoms appear.

The research was published in the journal Materials Today Bio.

Heart health & disease focus
#HeartHealth #Cardiovascular #Atherosclerosis #HeartDisease #StrokePrevention

Nanotech & biomedical innovation
#Nanomedicine #Nanoparticles #Theranostics #MedicalNanotech #AdvancedMaterials

Research & science
#MedicalBreakthrough #Biotech #TranslationalMedicine #FutureOfMedicine #CuttingEdgeScience

Regional / discovery angle (optional)
#AustraliaResearch #CanadaResearch #GlobalHealthInnovation

Scientists found a protein that carries "old age signals" through the body — and blocking it literally reversed the damage.

In a major breakthrough in aging research, scientists at Korea University’s College of Medicine have discovered that cellular aging can spread throughout the body via the bloodstream.

The culprit is ReHMGB1, a redox-sensitive version of a protein called HMGB1, which is secreted by aging, or senescent, cells. This protein was shown to trigger aging-like effects in distant, healthy tissues—reducing their ability to regenerate and harming muscle performance. In mouse models, researchers successfully blocked ReHMGB1 using antibodies, resulting in fewer signs of aging and improved recovery after injury.

This study, published in Metabolism – Clinical and Experimental, provides the first direct evidence that aging is not just a local cellular process but one that can be systemically transmitted through blood. By identifying ReHMGB1 as a key molecular messenger in this process, researchers now have a potential target for therapies aimed at slowing or even reversing age-related decline. The findings could have far-reaching implications for treating a range of conditions tied to aging, from muscle wasting to organ degeneration.

Source: Jeon, O. H., et al. (2025). Propagation of senescent phenotypes by extracellular HMGB1 is dependent on its redox state. Metabolism – Clinical and Experimental.

Longevity & aging research
#Longevity #AgingResearch #ReversingAging #HealthyAging #Senescence

Molecular & biomedical focus
#HMGB1 #ReHMGB1 #MolecularBiology #CellularSenescence #Biogerontology

Therapeutics & innovation
#AntiAging #RegenerativeMedicine #Biotech #TranslationalMedicine #FutureOfMedicine

General science & discovery
#MedicalBreakthrough #LifeSciences #CuttingEdgeScience #AgingScience

🧩 How are skin and gut inflammation connected?

🔗 Identification of shared and unique mechanisms of atopic dermatitis and ulcerative colitis by construction and computational analysis of disease maps. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.09.008

📚 CSBJ: https://www.csbj.org/

#Immunology #Dermatology #Gastroenterology #SystemsBiology #PrecisionMedicine #DrugDiscovery #ComputationalBiology #InflammationResearch #Biomarkers #TranslationalMedicine

Job Alert

Independent Junior Research Group Leader in “Translational Cancer Research”

Deadline: 2025-08-7
Location: Germany, Heidelberg, Freiburg

https://www.academiceurope.com/ads/independent-junior-research-group-leader-in-translational-cancer-research/

#hiring #CancerResearch #datascience #JuniorGroupLeader #BiomedicalScience #lifescience #TranslationalMedicine